Abstract
Objectives
Urologists can benefit from a standardized system for guideline development and presentation. This article introduces the GRADE system and explains how it may be useful for Urologic physicians, in their practice and in their healthcare systems.
Methods
The GRADE system is reviewed. Specific aspects of how GRADE rates the quality of the evidence and the strength of recommendations are explored.
Results
GRADE can provide explicit and structured guidance, which separates the quality of evidence from the strength of recommendations. This information can be used by consumers of guidelines, including patients, physicians, and policy makers.
Conclusions
Urologists can benefit from a more transparent and rigorous framework when formulating recommendations. GRADE is an emergent proposal with broader implications for healthcare policy as well.
This is a preview of subscription content, access via your institution.

References
Scottish Intercollegiate Guidelines Network (2008) SIGN 50: a guideline developer’s handbook. Scottish Intercollegiate Guidelines Network, Guideline no. 50
Scottish Intercollegiate Guidelines Network (2004) Management of urinary incontinence in primary care. Scottish Intercollegiate Guidelines Network, Guideline no. 79
Winn RJ, McClure JS (2003) The NCCN clinical practice guidelines in oncology (NCCN Guidelines™) NCCN Senior Vice President, Clinical Information & Publications
NCCN Guidelines Prostate Cancer (2010) National comprehensive cancer network, Version 1.2011
Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53:68
Thuroff JW, Abrams P, Andersson KE et al (2011) EAU guidelines on urinary incontinence. European urol 59(3):387–400
Guyatt GH, Oxman AD, Vist G et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Bmj 336:924
Schunemann HJ, Oxman AD, Brozek J et al (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. Bmj 336:1106
Guyatt GH, Oxman AD, Kunz R et al (2008) What is “quality of evidence” and why is it important to clinicians? Bmj 336:995
Guyatt GH, Oxman AD, Kunz R et al (2008) Incorporating considerations of resources use into grading recommendations. Bmj 336:1170
Guyatt GH, Oxman AD, Kunz R et al (2008) Going from evidence to recommendations. Bmj 336:1049
Oxman AD, Guyatt GH (1988) Guidelines for reading literature reviews. CMAJ 138:697
Seitz C, Liatsikos E, Porpiglia F et al (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56:455
Hollingsworth JM, Zhang Y, Krein SL et al (2010) Understanding the variation in treatment intensity among patients with early stage bladder cancer. Cancer 116:3587
Wolf JS Jr, Bennett CJ, Dmochowski RR et al (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379
Feldman DR, Bosl GJ, Sheinfeld J et al (2008) Medical treatment of advanced testicular cancer. JAMA 299:672
Meek PD, Evang SD, Tadrous M et al (2011) Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials. Dig Dis Sci 56(1):7–18
Canfield SE, Dahm P (2010) Evidence-based urology in practice: incorporating patient values in evidence-based clinical decision making. BJU Int 105:4
Herrmann TR, Merseburger AS, Burchardt M (2009) Considerations on prostate cancer: diagnosis and treatment decisions. World J Urol 27:579
Hunter KF, Glazener CM, Moore KN (2007) Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev (2):CD001843
Kantoff PW, Higano CS, Shore ND et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411
Preminger GM, Tiselius HG, Assimos DG et al (2007) Guideline for the management of ureteral calculi. J Urol 178:2418
Emanuel EJ (1996) Cost savings at the end of life. What do the data show? JAMA 275:1907
Seitz C, Liatsikos E, Porpiglia F et al (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56:455
Acknowledgments
This article relies heavily on the landmark series published in the British Medical Journal by the GRADE working group.
Conflict of interest
Dr. Dahm is a member of the GRADE working group.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Canfield, S.E., Dahm, P. Rating the quality of evidence and the strength of recommendations using GRADE. World J Urol 29, 311–317 (2011). https://doi.org/10.1007/s00345-011-0667-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-011-0667-2
Keywords
- Guidelines
- Levels of evidence
- Urology